Biofrontera Competitors and Similar CompaniesClear all
Affimed N.V.'s competitors and similar companies include Zogenix.
 Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. |  Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. | |
Founding Date | Founding Date 2000 | Founding Date 2006 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Heidelberg, DE HQ | Locations Emeryville, US HQ Maidenhead, GB |
Employees | Employees 76 | Employees 743% increase |
Financial | ||
Revenue (est.) | Revenue (est.) €8.3m (FY, 2023) | Revenue (est.) $81.7m (FY, 2021) |
Cost of goods | Cost of goods N/A | Cost of goods $4.8m (FY, 2021) |
Net income | Net income (€105.9m) (FY, 2023) | Net income ($227.4m) (FY, 2021) |
For sources of this data, please see the company profile
View Company Profiles
Zogenix
HQ
Emeryville, US
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
View company